At NBI Biosciences, we harness the power of active plant molecules to address diverse diseases and conditions, validated through rigorous scientific research. Our primary areas of focus encompass cholesterol, insulin, Parkinson’s disease, and SLIDD (Small Intestinal Bacterial Overgrowth). Additionally, we are committed to advancing future pipelines targeting COPD and mental health. Join us on our journey to pioneer biotechnological solutions for a healthier world.